Bartlett, John M S <br/><br/>
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.  [electronic resource] 

 -  Breast cancer research : BCR  2010 
 - R47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr2604  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--diagnosis<br/>Carcinoembryonic Antigen--metabolism<br/>Cell Cycle Proteins--metabolism<br/>Chemotherapy, Adjuvant<br/>Diagnostic Tests, Routine--methods<br/>Disease-Free Survival<br/>Female<br/>GPI-Linked Proteins--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Large Neutral Amino Acid-Transporter 1--metabolism<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local<br/>Prognosis<br/>Receptors, Estrogen--metabolism<br/>Reproducibility of Results<br/>Risk Assessment--methods<br/>Risk Factors<br/>Sensitivity and Specificity<br/>Tamoxifen--therapeutic use<br/>Tumor Suppressor Protein p53--metabolism